Skip to content

Homoeopathy and cervical lymphadenopathy

Effectiveness of Individualized Homoeopathic Medicine in Cervical Lymphadenopathy in children- Pilot, Open label study - NIL

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/10/059236
Enrollment
130
Registered
2023-10-27
Start date
Unknown
Completion date
Unknown
Last updated
2025-02-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: R221- Localized swelling, mass and lump,neck

Interventions

Intervention1: Individualized Homoeopathic medicines: Individualized homoeopathic medicines in centesimal potency will be prescribed as per the principles of Homoeopathy in cases of cervical lymphaden

Sponsors

Central Council for Research in Homoeopathy
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Children between 5 to 17 years,Sex: Both male and female,Single or multiple enlarged cervical lymph nodes or enlarged unilateral or bilateral cervical lymph node, At least 1 cervical lymph node should be more than 1 cm or palpable,Assent of children and consent of parents

Exclusion criteria

Exclusion criteria: Children suffering from Pulmonary Tuberculosis, Hodgkin’s lymphoma, malignancy, autoimmune disease Children on Anti Tubercular Treatment (ATT) in the last 6 months. Lymph node less than 1cm in size or at any other site such as inguinal or axillary areas

Design outcomes

Primary

MeasureTime frame
Change in number,location & size of the cervical lymph nodes Timepoint: Assessed fortnightly till end of 6 months

Secondary

MeasureTime frame
Change in mobility Change in consistencyTimepoint: Assessed fortnightly till end of 6 months Assessed fortnightly till end of 6 months

Countries

India

Contacts

Public ContactDr Divya Taneja

Central Council for Research in Homoeopathy

renumittal8@gmail.com9717511115

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026